Adeno-associated virus vectors can be efficiently produced without helper virus

被引:414
|
作者
Matsushita, T
Elliger, S
Elliger, C
Podsakoff, G
Villarreal, L
Kurtzman, GJ
Iwaki, Y
Colosi, P
机构
[1] Avigen Inc, Alameda, CA USA
[2] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA
[3] Univ So Calif, Sch Med, Dept Urol, Los Angeles, CA 90033 USA
关键词
AAV vector production; AAV helper genes; adenovirus;
D O I
10.1038/sj.gt.3300680
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of this work was to develop an efficient method for the production of adeno-associated virus (AAV) vectors in the absence of helper virus. The adenovirus regions that mediate AAV vector replication were identified and assembled into a helper plasmid. These included the VA, E2A and E4 regions. When this helper plasmid was cotransfected into 293 cells, along with plasmids encoding the AAV vector, and rep and cap genes, AAV vector was produced as efficiently as when using adenovirus infection as a source of help. CMV-driven constructs expressing the E4orf6 and the 72-M-r, E2A proteins were able to functionally replace the E4 and E2A regions, respectively. Therefore the minimum set of genes required to produce AAV helper activity equivalent to that provided by adenovirus infection consists of, or is a subset of, the following genes: the E4orf6 gene, the 72-M-r, E2A protein gene, the VA RNA genes and the E1 region. AAV vector preparations made with adenovirus and by the helper virus-free method were essentially indistinguishable with respect to particle density, particle to infectivity ratio, capsimer ratio and efficiency of muscle transduction in vivo. Only AAV vector preparations made by the helper virus-free method were not reactive with anti-adenovirus sera.
引用
收藏
页码:938 / 945
页数:8
相关论文
共 50 条
  • [21] Immune responses to adenovirus and adeno-associated virus in humans
    N Chirmule
    K J Propert
    S A Magosin
    Y Qian
    R Qian
    J M Wilson
    Gene Therapy, 1999, 6 : 1574 - 1583
  • [22] Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus
    Zhang, HG
    Wang, YM
    Xie, JF
    Liang, X
    Hsu, HC
    Zhang, X
    Douglas, J
    Curiel, DT
    Mountz, JD
    GENE THERAPY, 2001, 8 (09) : 704 - 712
  • [23] RECOMBINANT ADENO-ASSOCIATED VIRUS DERIVED VECTORS (rAAV2) EFFICIENTLY TRANSDUCE OVARIAN AND HEPATOCELLULAR CARCINOMA CELLS - IMPLICATIONS FOR CANCER GENE THERAPY
    Makecki, Maciej
    Swoboda, Pawel
    Pachecka, Jan
    ACTA POLONIAE PHARMACEUTICA, 2009, 66 (01): : 93 - 99
  • [24] Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus
    H-G Zhang
    Y M Wang
    J F Xie
    X Liang
    H-C Hsu
    X Zhang
    J Douglas
    D T Curiel
    J D Mountz
    Gene Therapy, 2001, 8 : 704 - 712
  • [25] Applications and Limitations of Equilibrium Density Gradient Analytical Ultracentrifugation for the Quantitative Characterization of Adeno-Associated Virus Vectors
    Hirohata, Kiichi
    Yamaguchi, Yuki
    Maruno, Takahiro
    Shibuya, Risa
    Torisu, Tetsuo
    Onishi, Takayuki
    Chono, Hideto
    Mineno, Junichi
    Yuzhe, Yuan
    Higashiyama, Kiyoko
    Masumi-Koizumi, Kyoko
    Uchida, Kazuhisa
    Yamamoto, Takenori
    Uchida, Eriko
    Okada, Takashi
    Uchiyama, Susumu
    ANALYTICAL CHEMISTRY, 2024, 96 (02) : 642 - 651
  • [26] Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus
    X L Liu
    K R Clark
    P R Johnson
    Gene Therapy, 1999, 6 : 293 - 299
  • [27] Stable transduction of large DNA by high-capactity adeno-associated virus/adenovirus hybrid vectors
    Gonçalves, MAFV
    van der Velde, L
    Knaän-Shanzer, S
    Valerio, D
    de Vries, AAF
    VIROLOGY, 2004, 321 (02) : 287 - 296
  • [28] Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus
    Liu, XL
    Clark, KR
    Johnson, PR
    GENE THERAPY, 1999, 6 (02) : 293 - 299
  • [29] Adeno-Associated Virus Vector Mobilization, Risk Versus Reality
    Song, Liujiang
    Samulski, R. Jude
    Hirsch, Matthew L.
    HUMAN GENE THERAPY, 2020, 31 (19-20) : 1054 - 1067
  • [30] Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors
    M Mitchell
    M Jerebtsova
    ML Batshaw
    K Newman
    X Ye
    Gene Therapy, 2000, 7 : 1986 - 1992